These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1826567)

  • 1. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.
    Parish DC; Muecke HW; Joiner TA; Pope WT; Hadler SC
    South Med J; 1991 Apr; 84(4):426-30. PubMed ID: 1826567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped.
    Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S
    J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity and safety of intradermal hepatitis B vaccine.
    Toffler WL; Olenick JS; Wolf NE; Retzlaff ZH; Swanson JR; Kenny TA
    J Fam Pract; 1991 Aug; 33(2):149-54. PubMed ID: 1832438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.
    Bryan JP; Sjogren M; Iqbal M; Khattak AR; Nabi S; Ahmed A; Cox B; Morton A; Shuck J; Macarthy P
    J Infect Dis; 1990 Oct; 162(4):789-93. PubMed ID: 2144866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines.
    Söyletir G; Bahçeci E; Akoğlu E; Soyoğul U; Lawrance RA
    Vaccine; 1992; 10(5):301-4. PubMed ID: 1533478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine.
    Lancaster D; Elam S; Kaiser AB
    Am J Infect Control; 1989 Jun; 17(3):126-9. PubMed ID: 2742197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly.
    King JW; Taylor EM; Crow SD; White MC; Todd JR; Poe MB; Conrad SA; Gelder FB
    Rev Infect Dis; 1990; 12(6):1035-43. PubMed ID: 2148433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel--a preliminary report.
    Prasetya E; Linggadjaja W; Syambali R; Kusumo S; Dharmesetyawan DF; Rahardja U
    Ann Acad Med Singap; 1986 Apr; 15(2):153-7. PubMed ID: 2944466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal vaccination against hepatitis B in a group of medical students.
    Brink NS; Murray AB
    S Afr Med J; 1991 Jun; 79(11):653-4. PubMed ID: 1828632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal hepatitis B vaccination in a 300-bed primary care hospital: experience with a recombinant vaccine in a four-dose schedule.
    McMaster KR; Roper JK; Carter JB
    Am J Infect Control; 1993 Dec; 21(6):283-8. PubMed ID: 8122799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine.
    Horowitz MM; Ershler WB; McKinney WP; Battiola RJ
    Ann Intern Med; 1988 Feb; 108(2):185-9. PubMed ID: 2963570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against hepatitis B: comparison of intradermal and intramuscular administration of plasma derived and recombinant vaccines.
    Payton CD; Scarisbrick DA; Sikotra S; Flower AJ
    Epidemiol Infect; 1993 Feb; 110(1):177-80. PubMed ID: 8432320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.
    Wahl M; Hermodsson S
    Scand J Infect Dis; 1987; 19(6):617-21. PubMed ID: 3441747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal, low dose, short course hepatitis B vaccination.
    Goldwater PN; Woodfield DG; Ramirez AM; Anzimlt IS
    N Z Med J; 1986 Sep; 99(810):703-5. PubMed ID: 2950344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
    Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
    Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.